Prognostic parameters of endometrial carcinoma

被引:255
作者
Prat, J [1 ]
机构
[1] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Pathol, Barcelona 08025, Spain
关键词
endometrial carcinoma; grade; FIGO stage; prognosis;
D O I
10.1016/j.humpath.2004.02.007
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Endometrial carcinoma is the most common malignant tumor of the female genital tract in the Western world. Approximately 80% of cases are well- to moderately differentiated (endometrioid) adenocarcinomas, which are confined to the uterine corpus at diagnosis, and thus most can be cured. Conversely, high-grade (ie, clear cell and serous) carcinomas account for only 15% to 20% of cases and show marked nuclear atypia. These tumors usually invade the myometrium and may extend beyond the uterus at the time of hysterectomy. In addition to clinical and morphological differences, these 2 groups of endometrial carcinomas differ in their pathogenesis. Whereas prognosis in the latter group is generally poor, the pathologist's role in establishing the outcome in the former group is crucial. Furthermore, it has become progressively apparent that both groups overlap to some extent, making the dualistic model a guideline at best. Over the last 2 decades, several studies have demonstrated the prognostic importance of various key surgical and pathological parameters, including histological type, histological grade, surgical-pathological stage, depth of myometrial invasion, vascular invasion, and cervical involvement. This review presents the most important prognostic factors of endometrial carcinomas from the pathologist's viewpoint, and attempts to clarify existing conflicts in the classification and diagnosis of these tumors. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:649 / 662
页数:14
相关论文
共 130 条
[11]   Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO Stage 1a and 1b endometrial adenocarcinoma: Treatment implications [J].
Aquino-Parsons, C ;
Lim, P ;
Wong, F ;
Mildenberger, M .
GYNECOLOGIC ONCOLOGY, 1998, 71 (01) :83-86
[12]   ENDOMETRIAL CARCINOMA - NONTUMOR FACTORS IN PROGNOSIS [J].
BECKNER, ME ;
MORI, T ;
SILVERBERG, SG .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1985, 4 (02) :131-145
[13]   OVEREXPRESSION OF HER-2 NEU IN ENDOMETRIAL CANCER IS ASSOCIATED WITH ADVANCED STAGE DISEASE [J].
BERCHUCK, A ;
RODRIGUEZ, G ;
KINNEY, RB ;
SOPER, JT ;
DODGE, RK ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) :15-21
[14]   2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA [J].
BOKHMAN, JV .
GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :10-17
[15]   Surgical staging of endometrial cancer: Evolution, evaluation, and responsible challenge - A personal perspective [J].
Boronow, RC .
GYNECOLOGIC ONCOLOGY, 1997, 66 (02) :179-189
[16]  
BORONOW RC, 1984, OBSTET GYNECOL, V63, P825
[17]   FLOW CYTOMETRIC DNA ANALYSIS OF STAGE-1 ENDOMETRIAL CARCINOMA [J].
BRITTON, LC ;
WILSON, TO ;
GAFFEY, TA ;
LIEBER, MM ;
WIEAND, HS ;
PODRATZ, KC .
GYNECOLOGIC ONCOLOGY, 1989, 34 (03) :317-322
[18]   PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases [J].
Bussaglia, E ;
del Rio, E ;
Matias-Guiu, X ;
Prat, J .
HUMAN PATHOLOGY, 2000, 31 (03) :312-317
[19]  
Caduff RF, 1996, AM J PATHOL, V148, P1671
[20]   UTERINE PAPILLARY SEROUS CARCINOMA - A STUDY ON 108 CASES WITH EMPHASIS ON THE PROGNOSTIC-SIGNIFICANCE OF ASSOCIATED ENDOMETRIOID CARCINOMA, ABSENCE OF INVASION, AND CONCOMITANT OVARIAN-CARCINOMA [J].
CARCANGIU, ML ;
CHAMBERS, JT .
GYNECOLOGIC ONCOLOGY, 1992, 47 (03) :298-305